A surveillance study over a 10-year period in the Gambia found that routine introduction of PCV led to a 33% reduction in the incidence of radiological pneumonia and a 27% decline in pneumonia hospitalizations in children. Reducing the rate of pneumococcal disease will not only save lives but will also reduce the substantial economic burden placed on families and health systems.
Full Citation:
Mackenzie GA, Hill PC, Jeffries DJ et al.. 2021. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance. The Lancet Infectious Diseases. 21(9).
Title of Article: Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance
Author(s): Mackenzie GA, Hill PC, Jeffries DJ et al.
Publication Year: 2021
Publication Name: The Lancet Infectious Diseases
Publication Volume: 21(9)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/34280357/
DOI (Digital Object Identifier): 10.1016/S1473-3099(20)30880-X
Topics: Economics & Return on Investment
Disease Vaccines: Pneumococcal disease/PCV/PPSV
Immunization Terms: Hospitalizations
Countries: Gambia
WHO Regions: Africa